Drug Approval | April 21, 2026
Orbicular's partner secures tentative U.S. ANDA approval for a generic version of Ozempic
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
AI-enabled learning platform to enhance clinical quality, patient outcomes, and staff engagement across Eastern India network
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
The launch coincides with IBS Awareness Month in April
The innovation is particularly suited for bone and cartilage repair
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
Subscribe To Our Newsletter & Stay Updated
